Targeting Pin1 Renders Pancreatic Cancer Eradicable by Synergizing with Immunochemotherapy

Researchers found that Pin1 was overexpressed both in cancer cells and cancer-associated fibroblasts and correlated with poor survival in pancreatic ductal adenocarcinoma patients.